Frank Rimerman Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Frank Rimerman Advisors's NVS Position: Q2 2026 in Review
Frank Rimerman Advisors increased its Novartis (NVS) stake by 1.1% in Q2 2026, buying an estimated $18.7K and bringing the position to 11,569 shares worth $1.81M. The position accounts for 0.1% of the portfolio, ranked #156.
Frank Rimerman Advisors first reported a position in NVS in Q2 2024 and has held it in 8 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Frank Rimerman Advisors held 11,569 shares of Novartis worth $1.81M as of Q2 2026.
- Frank Rimerman Advisors bought 125 Novartis shares in Q2 2026, an estimated $18.7K.
- Novartis made up 0.1% of Frank Rimerman Advisors's portfolio in Q2 2026, its #156 holding.
- Frank Rimerman Advisors first reported a position in Novartis in Q2 2024 and has held it in 8 quarters since.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.